Group leader developing molecular therapies for inherited neurometabolic and retinal diseases at the Radboudumc 👁️🧪🧬 From Barcelona,📍based in Nijmegenhttps://bsky.app/profile/jandritu.bsky.socialhttps://bsky.app/profile/jandritu.bsky.social/post/3luhlyyiqrd2s🚨 PhD position available 🚨 👀 We are excited to announce a fully funded PhD position in our lab, focused on developing personalized induced pluripotent stem cell (iPSC)-based models to study inherited retinal diseases as part of the Lifelong VISION consortium!21 Jul 2025 08:45 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3luhlyyiqrd2shttps://bsky.app/profile/jandritu.bsky.social/post/3luhltndbhs2s💡 Light matters 💡 Despite major advances in generating retinal cells in vitro, these cells are typically cultured in the dark. But why would cells develop light-sensitive features if there is no light around?21 Jul 2025 08:42 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3luhltndbhs2shttps://bsky.app/profile/jandritu.bsky.social/post/3ljp3g65xlc2r🚨𝗙𝗶𝗻𝗮𝗹 𝗪𝗲𝗲𝗸 𝘁𝗼 𝗔𝗽𝗽𝗹𝘆 𝘁𝗼 𝟭𝟮 𝗙𝘂𝗹𝗹𝘆 𝗙𝘂𝗻𝗱𝗲𝗱 𝗣𝗵𝗗 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝗙𝗙𝗲𝗰𝗧🚨 🔬 Join an international network driving innovative treatments and delivery methods for a variety of disorders with leading experts in RNA therapeutics 🌍 🔗 𝗔𝗽𝗽𝗹𝘆 𝗻𝗼𝘄: euraxess.ec.europa.eu/jobs/296420 more info: www.effect-dn.eu https://euraxess.ec.europa.eu/jobs/29642006 Mar 2025 08:32 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3ljp3g65xlc2rhttps://bsky.app/profile/jandritu.bsky.social/post/3ljaarjgq5s2b5 Partners & 1 Associated partner of #EFFecT are present at SMOT (Synergistic Meeting on Oligonucleotide Therapeutics) celebrating #rarediseaseday.@radboudumc.bsky.social @dutchantisense.bsky.social @uvsq.bsky.social #ucl @cbm-csic-uam.bsky.social @varechavala.bsky.social28 Feb 2025 10:58 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3ljaarjgq5s2bhttps://bsky.app/profile/jandritu.bsky.social/post/3lif77ihyck24🚨 Only 3 Weeks Left to Apply! 🚨 Passionate about antisense oligonucleotide (ASO) therapeutics? Looking for a PhD opportunity in this cutting-edge field? The EFFecT consortium is recruiting!17 Feb 2025 16:48 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3lif77ihyck24https://bsky.app/profile/jandritu.bsky.social/post/3lgkhs733ct2rCheck out our latest work! Preclinical in vitro and safety and in vivo biodistribution of #antisense #oligonucleotides targeting a recurrent genetic variant in ABCA4 present in patients with #Stargardt disease. A big first step towards therapeutic intervention. https://www.nature.com/articles/s43856-024-00712-725 Jan 2025 08:14 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3lgkhs733ct2rhttps://bsky.app/profile/jandritu.bsky.social/post/3lgjki3beyl2rToday part of the @dutch-antisense.bsky.social organizing committee visited the venues for the #DATS2025 in Groningen! We cannot wait to welcoming you in June! Registrations will open soon, stay tuned! www.dutchantisense.org @ronaldbuijsen.bsky.social24 Jan 2025 23:30 +0000at://did:plc:p2jjpctotdae4eufuzivtv62/app.bsky.feed.post/3lgjki3beyl2r